Critical Makeover
Apr 15, 2021
4 minutes
By Hu Fan
Representatives of over 100 pharmaceutical companies gathered in a hotel in Shanghai on February 3. Documents in hand, they were there to attend a centralized procurement session organized by China’s health authority.
This was the fourth time such a centralized procurement took place. The organizers had collected the information on the needs of public hospitals across the country for 45 kinds of drugs. They invited pharmaceutical companies there to bid for procurement contracts.
The competition was fierce. At the end of the meeting, 158 products were chosen with price cuts of 52 percent on average
You’re reading a preview, subscribe to read more.
Start your free 30 days